Results 1 to 10 of about 122,201 (120)
Metabolites, 2021 There is a strong association between hepatocyte phospholipid homeostasis and non-alcoholic fatty liver disease (NAFLD). The phosphatidylcholine to phosphatidylethanolamine ratio (PC/PE) often draws special attention as genetic and dietary disruptions to
Kang-Yu Peng +7 more
doaj +1 more source
Frontiers in Endocrinology, 2023 BackgroundThe negative effects of obesity on hepatic steatosis and fibrosis have received considerable attention in recent years. The weight-adjusted-waist index (WWI) reflects weight-independent centripetal obesity.
Yun Shen +10 more
doaj +1 more source
Molecules, 2023 Lipid metabolism pathways such as β-oxidation, lipolysis and, lipogenesis, are mainly associated with normal liver function. However, steatosis is a growing pathology caused by the accumulation of lipids in hepatic cells due to increased lipogenesis ...
Francisca S. Teixeira +5 more
doaj +1 more source
Endocrine Connections, 2021 Background and aims: Non-alcoholic fatty liver disease (NAFLD) has become a common chronic liver disease in the world. Simple steatosis (SS) is the early phase of NAFLD.
Xu Chen +4 more
doaj +1 more source
The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
Frontiers in Immunology, 2021 The complex interplay between the gut microbiota, the intestinal barrier, the immune system and the liver is strongly influenced by environmental and genetic factors that can disrupt the homeostasis leading to disease.
Rosa Martín-Mateos, Agustín Albillos
doaj +1 more source
PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE
Фармакоэкономика, 2015 Chronic liver diseases are a serious problem and a common cause of suffering and death in all countries. Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver diseases.
D. V. Blinov +2 more
doaj +1 more source
Неотложная медицинская помощь, 2018 We performed the clinical and morphological analysis of 84 elderly and senile patients, died of poisonings with psychoactive drugs in 2013–2015. There were two main drug agents: benzodiazepines and barbiturates. During the first 5 days intoxication was a
L. N. Zimina +6 more
doaj +1 more source
Frontiers in Pharmacology, 2020 Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease with high prevalence in the developed countries. NAFLD has been considered as one of the leading causes of cryptogenic cirrhosis and chronic liver disease.
Yu Xu +7 more
doaj +1 more source
Knowing what’s out there: awareness of Non Alcoholic Fatty Liver Disease.
Frontiers in Medicine, 2014 Background: Non Alcoholic Fatty Liver Disease (NAFLD) is the most common hepatic disorder, which poses a significant health burden in the western countries. As the epidemic of obesity slides health downward, the incidence of NAFLD is evidently increasing.
Vishal eGhevariya +6 more
doaj +1 more source
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis [PDF]
Clinical and Molecular Hepatology, 2021 Background/Aims Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis.
Gang Xu +8 more
doaj +1 more source